DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
20.72
-0.10 (-0.48%)
Nov 18, 2026, 2:45 PM CST
| Market Cap | 23.60B +11.3% |
| Revenue (ttm) | 28.74B +7.1% |
| Net Income | 1.43B +25.3% |
| EPS | 1.25 +23.4% |
| Shares Out | 1.14B |
| PE Ratio | 16.59 |
| Forward PE | 16.72 |
| Dividend | 0.90 (4.34%) |
| Ex-Dividend Date | Oct 19, 2026 |
| Volume | 9,915,725 |
| Open | 20.65 |
| Previous Close | 20.82 |
| Day's Range | 20.48 - 20.96 |
| 52-Week Range | 14.39 - 21.78 |
| Beta | 0.33 |
| Analysts | Buy |
| Price Target | 24.03 (+15.98%) |
| Earnings Date | Oct 30, 2026 |